Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major (Q34571253)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major |
scientific article |
Statements
1 reference
Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major (English)
1 reference
Renzo Galanello
1 reference
Antonio Piga
1 reference
Gian Luca Forni
1 reference
Yves Bertrand
1 reference
Maria Loreta Foschini
1 reference
Elena Bordone
1 reference
Giovanbattista Leoni
1 reference
Antonella Lavagetto
1 reference
Antonietta Zappu
1 reference
Filomena Longo
1 reference
Henry Maseruka
1 reference
Nicola Hewson
1 reference
Romain Sechaud
1 reference
Rossella Belleli
1 reference
Daniele Alberti
1 reference
1 October 2006
1 reference
1 reference